These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 23379513)

  • 41. [Congenital muscular dystrophy and alpha-dystroglycanopathy].
    Saito F; Matsumura K; Hagiwara H; Shimizu T
    Rinsho Shinkeigaku; 2008 Aug; 48(8):543-9. PubMed ID: 18939472
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Congenital muscular dystrophies involving the O-mannose pathway.
    Martin PT
    Curr Mol Med; 2007 Jun; 7(4):417-25. PubMed ID: 17584082
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Transgenic overexpression of LARGE induces α-dystroglycan hyperglycosylation in skeletal and cardiac muscle.
    Brockington M; Torelli S; Sharp PS; Liu K; Cirak S; Brown SC; Wells DJ; Muntoni F
    PLoS One; 2010 Dec; 5(12):e14434. PubMed ID: 21203384
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Muscle-specific expression of LARGE restores neuromuscular transmission deficits in dystrophic LARGE(myd) mice.
    Gumerson JD; Davis CS; Kabaeva ZT; Hayes JM; Brooks SV; Michele DE
    Hum Mol Genet; 2013 Feb; 22(4):757-68. PubMed ID: 23222475
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Glycosylation with ribitol-phosphate in mammals: New insights into the O-mannosyl glycan.
    Manya H; Endo T
    Biochim Biophys Acta Gen Subj; 2017 Oct; 1861(10):2462-2472. PubMed ID: 28711406
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Missense mutations in β-1,3-N-acetylglucosaminyltransferase 1 (B3GNT1) cause Walker-Warburg syndrome.
    Buysse K; Riemersma M; Powell G; van Reeuwijk J; Chitayat D; Roscioli T; Kamsteeg EJ; van den Elzen C; van Beusekom E; Blaser S; Babul-Hirji R; Halliday W; Wright GJ; Stemple DL; Lin YY; Lefeber DJ; van Bokhoven H
    Hum Mol Genet; 2013 May; 22(9):1746-54. PubMed ID: 23359570
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Promoter alteration causes transcriptional repression of the POMGNT1 gene in limb-girdle muscular dystrophy type 2O.
    Raducu M; Baets J; Fano O; Van Coster R; Cruces J
    Eur J Hum Genet; 2012 Sep; 20(9):945-52. PubMed ID: 22419172
    [TBL] [Abstract][Full Text] [Related]  

  • 48.
    Yonekawa T; Rauckhorst AJ; El-Hattab S; Cuellar MA; Venzke D; Anderson ME; Okuma H; Pewa AD; Taylor EB; Campbell KP
    Sci Adv; 2022 May; 8(21):eabn0379. PubMed ID: 35613260
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Amelioration of laminin-alpha2-deficient congenital muscular dystrophy by somatic gene transfer of miniagrin.
    Qiao C; Li J; Zhu T; Draviam R; Watkins S; Ye X; Chen C; Li J; Xiao X
    Proc Natl Acad Sci U S A; 2005 Aug; 102(34):11999-2004. PubMed ID: 16103356
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expression and localization of fukutin, POMGnT1, and POMT1 in the central nervous system: consideration for functions of fukutin.
    Yamamoto T; Kato Y; Kawaguchi M; Shibata N; Kobayashi M
    Med Electron Microsc; 2004 Dec; 37(4):200-7. PubMed ID: 15614444
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Recent advances in congenital muscular dystrophy research].
    Nonaka I
    No To Hattatsu; 2005 Mar; 37(2):115-21. PubMed ID: 15773323
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Fukuyama congenital muscular dystrophy and related alpha-dystroglycanopathies].
    Murakami T; Nishino I
    Brain Nerve; 2008 Oct; 60(10):1159-64. PubMed ID: 18975603
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fukutin expression in mouse non-muscle somatic organs: its relationship to the hypoglycosylation of alpha-dystroglycan in Fukuyama-type congenital muscular dystrophy.
    Saito Y; Yamamoto T; Ohtsuka-Tsurumi E; Oka A; Mizuguchi M; Itoh M; Voit T; Kato Y; Kobayashi M; Saito K; Osawa M
    Brain Dev; 2004 Oct; 26(7):469-79. PubMed ID: 15351084
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Carbohydrate-binding domain of the POMGnT1 stem region modulates O-mannosylation sites of α-dystroglycan.
    Kuwabara N; Manya H; Yamada T; Tateno H; Kanagawa M; Kobayashi K; Akasaka-Manya K; Hirose Y; Mizuno M; Ikeguchi M; Toda T; Hirabayashi J; Senda T; Endo T; Kato R
    Proc Natl Acad Sci U S A; 2016 Aug; 113(33):9280-5. PubMed ID: 27493216
    [TBL] [Abstract][Full Text] [Related]  

  • 55. biAb Mediated Restoration of the Linkage between Dystroglycan and Laminin-211 as a Therapeutic Approach for α-Dystroglycanopathies.
    Gumlaw N; Sevigny LM; Zhao H; Luo Z; Bangari DS; Masterjohn E; Chen Y; McDonald B; Magnay M; Travaline T; Yoshida-Moriguchi T; Fan W; Reczek D; Stefano JE; Qiu H; Beil C; Lange C; Rao E; Lukason M; Barry E; Brondyk WH; Zhu Y; Cheng SH
    Mol Ther; 2020 Feb; 28(2):664-676. PubMed ID: 31843448
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Muscular dystrophies due to defective glycosylation of dystroglycan.
    Muntoni F; Brockington M; Godfrey C; Ackroyd M; Robb S; Manzur A; Kinali M; Mercuri E; Kaluarachchi M; Feng L; Jimenez-Mallebrera C; Clement E; Torelli S; Sewry CA; Brown SC
    Acta Myol; 2007 Dec; 26(3):129-35. PubMed ID: 18646561
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Transgenic Rescue of the LARGEmyd Mouse: A LARGE Therapeutic Window?
    Hildyard JC; Lacey E; Booler H; Hopkinson M; Wells DJ; Brown SC
    PLoS One; 2016; 11(7):e0159853. PubMed ID: 27467128
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ribitol restores functionally glycosylated α-dystroglycan and improves muscle function in dystrophic FKRP-mutant mice.
    Cataldi MP; Lu P; Blaeser A; Lu QL
    Nat Commun; 2018 Aug; 9(1):3448. PubMed ID: 30150693
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Overexpression of the CT GalNAc transferase inhibits muscular dystrophy in a cleavage-resistant dystroglycan mutant mouse.
    Jayasinha V; Hoyte K; Xia B; Martin PT
    Biochem Biophys Res Commun; 2003 Mar; 302(4):831-6. PubMed ID: 12646245
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Glycosylation defects: a new mechanism for muscular dystrophy?
    Grewal PK; Hewitt JE
    Hum Mol Genet; 2003 Oct; 12 Spec No 2():R259-64. PubMed ID: 12925572
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.